Omnicell, Inc.
$37.8
▲
0.62%
2026-04-21 08:37:01
www.omnicell.com
NMS: OMCL
Explore Omnicell, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.72 B
Current Price
$37.8
52W High / Low
$55 / $22.66
Stock P/E
839.18
Book Value
$27.36
Dividend Yield
—
ROCE
0.34%
ROE
0.17%
Face Value
—
EPS
$0.04
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
3,580
Beta
0.86
Debt / Equity
16.59
Current Ratio
1.43
Quick Ratio
1.22
Forward P/E
16.48
Price / Sales
1.32
Enterprise Value
$1.57 B
EV / EBITDA
34.48
EV / Revenue
1.33
Rating
Strong Buy
Target Price
$57.43
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Hinge Health, Inc. | $43.93 | — | $3.41 B | — | -142.9% | -1.33% | $62.18 / $30.08 | $2.26 |
| 2. | Spok Holdings, Inc. | $11.48 | 14.99 | $237.98 M | 10.89% | 12.85% | 10.55% | $19.31 / $10.81 | $7.1 |
| 3. | 10x Genomics, Inc. | $24.59 | — | $3.14 B | — | -12.49% | -5.78% | $26.45 / $7.25 | $6.24 |
| 4. | HealthStream, Inc. | $21.34 | 34.36 | $630.28 M | 0.6% | 5.11% | 5.14% | $34.13 / $19.5 | $11.97 |
| 5. | Simulations Plus, Inc. | $14.97 | — | $295 M | 0.61% | 5.18% | -41.21% | $36.45 / $11.09 | $6.31 |
| 6. | SOPHiA GENETICS SA | $5.19 | — | $371.96 M | — | -63.03% | -1.1% | $5.7 / $2.58 | $0.69 |
| 7. | Health Catalyst, Inc. | $1.26 | — | $92.72 M | — | -10.35% | -58.26% | $5.06 / $0.96 | $3.41 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 313.98 M | 310.63 M | 290.56 M | 269.67 M | 306.88 M |
| Operating Profit | 0.41 M | 8.24 M | 8.12 M | -11.62 M | 12.4 M |
| Net Profit | -2.03 M | 5.46 M | 5.64 M | -7.02 M | 15.84 M |
| EPS in Rs | -0.04 | 0.12 | 0.12 | -0.15 | 0.35 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 1.18 B | 1.11 B | 1.15 B | 1.3 B |
| Operating Profit | 5.16 M | 0.34 M | -34.87 M | -2.32 M |
| Net Profit | 2.05 M | 12.53 M | -20.37 M | 5.65 M |
| EPS in Rs | 0.05 | 0.28 | -0.45 | 0.12 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 1.97 B | 2.12 B | 2.23 B | 2.21 B |
| Total Liabilities | 742.91 M | 877.65 M | 1.04 B | 1.08 B |
| Equity | 1.23 B | 1.24 B | 1.19 B | 1.13 B |
| Current Assets | 680.07 M | 815.49 M | 927.57 M | 881.81 M |
| Current Liabilities | 476.61 M | 595.68 M | 367.79 M | 428.45 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 127.3 M | 187.72 M | 181.09 M | 77.78 M |
| Investing CF | -60.36 M | -52.79 M | -55.02 M | -58.67 M |
| Financing CF | -218.32 M | -235.58 M | 23.42 M | -20.95 M |
| Free CF | 69.37 M | 134.93 M | 126.08 M | 17.04 M |
| Capex | -57.93 M | -52.79 M | -55.02 M | -60.74 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 6.53% | -3.04% | -11.48% | — |
| Earnings Growth % | -83.62% | 161.51% | -460.68% | — |
| Profit Margin % | 0.17% | 1.13% | -1.78% | 0.44% |
| Operating Margin % | 0.44% | 0.03% | -3.04% | -0.18% |
| Gross Margin % | 42.49% | 42.35% | 43.31% | 45.45% |
| EBITDA Margin % | 7.75% | 8.1% | 5.29% | 7.47% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.